Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Colonic Neoplasms × dostarlimab × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Triple Negative Breast Neoplasms 1 Pathologic Complete Response 1 Neoplasms 1 Hemangiosarcoma 1 Endometrial Neoplasms 1 Colonic Neoplasms 1 Breast Neoplasms 1

Interventions

Oxaliplatin 9 Cetuximab 8 Bevacizumab 7 pembrolizumab 5 Leucovorin 5 Fluorouracil 5 Irinotecan 4 Pemetrexed 3 Gemcitabine 3 Cisplatin 3 Carboplatin 3 Capecitabine 3 fludarabine 2 adagrasib 2 Specimen Handling 2 Paclitaxel 2 Folfox protocol 2 Cyclophosphamide 2 Albumin-Bound Paclitaxel 2 130-nm albumin-bound paclitaxel 2 trifluridine tipiracil drug combination 1 trastuzumab deruxtecan 1 sintilimab 1 ropidoxuridine 1 relatlimab 1 palbociclib 1 encorafenib 1 durvalumab 1 dostarlimab 1 dehydroftorafur 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06567782 2026-03-12

AZUR-4

GlaxoSmithKline

Phase 2 Recruiting

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡